Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Topline Results from Phase 2b ‘X-TOLE’ Clinical Trial of XEN1101

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. TAP
3. DELL
4. ROIV
5. ANET
6. NKE
7. PANW
8. CL
9. SNDK
10. SPG

Go back to Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Topline Results from Phase 2b ‘X-TOLE’ Clinical Trial of XEN1101
(NASDAQ: XENE) Delayed: 59.75 -0.65 (1.08%)
Previous Close $60.40    52 Week High $9.75 
Open $60.02    52 Week Low $5.65 
Day High $60.57    P/E N/A 
Day Low $59.43    EPS $0.00 
Volume 459,232